The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on
Estimating production costs in the economic evaluation of health-care programs
β Scribed by Carmen Herrero; Juan D. Moreno-Ternero
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 160 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.1345
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive βeffort.β This method could be used within a costβeffectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatment programs, or public health interventions. We apply it to show evidence in favor of implementing a newborn screening program to detect congenital hearing impairment. Copyright Β© 2008 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
This paper addresses the issue of biases in cost measures which are used in economic evaluation studies. The basic measure of hospital costs which is used by most investigators is unit cost. Focusing on this measure, a set of criteria which the basic measures must fulfil in order to approximate the
## Abstract In the economic evaluation of health care programmes, productivity costs are often estimated using patients' wages for the period of absence. However, the use of such methods for short periods of absence is controversial. A previous study found that shortβterm absence is often compensat
To date, a common view in the health economics literature is that the applicability of cost-benefit analysis (CBA) is limited, due to the distribution problem which underlies its main method of valuation (e.g. willingness to pay). One view is that cost effectiveness analysis (CEA) overcomes these pr
## Abstract In the recent past, considerable effort in health economics has been made on applying stated preference methods such as contingent valuation and choice experiments. Despite this increased use, there is still considerable scepticism concerning the value of these approaches. The applicati
Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i